EFPIA - NEWSLETTER

EFPIA Newsletter 23 November 2017

News

20 November 2017 20112017 EFPIA welcomes the future location of the EMA decision has been made; now the focus...

EFPIA congratulates Amsterdam on being selected as the new location for the EMA

20 November 2017 20112017 OECD data shows long-term care drive health expenditure, health outcome variations...

The report provides an overview of overall health status in OECD countries, and how medical progress has contributed...

23 November 2017 22112017 EBE and EFPIA call for policy support to make personalised medicine a reality for...

The Manifesto sets out the necessary next steps that will enable a change in the European policy environment

Blogs

10 November 2017 10112017 Why I Won’t Rest

The story behind #WeWontRest is a big part of why I joined the pharmaceutical industry: the exciting science, the passion,...

17 November 2017 17112017 Incentives, IP and smaller companies - Case story: Vaxeal

How Vaxeal wants to change patients’ lives by improving health outcomes

Documents

Assessing the impact of proposals for a Supplementary Protection Certificate (SPC) Manufacturing... 27 October 2017 (Publications)

A study by QuintilesIMS

Working together with patient groups 11 October 2017 (Publications)

A publication from the Patient Think Tank to provide guidance for collaboration

Health Collaboration Guide 2017 26 October 2017 (Publications)

Showcasing best practice collaborations between patient organisations and industry, but also local authorities, governments,...

What we are reading

UK pharmaceutical sector prepares for hard Brexit as regulator exits 21 November 2017 (Financial Times)

State of Health in the EU 22 November 2017 (European Commission)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶